Key facts
- This page summarizes David E. Wheadon's Form 4 filing for ChemoCentryx, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 31 May 2022, 21:43.
David E. Wheadon - 26 May 2022 Form 4 Insider Report for ChemoCentryx, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 26 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 31 May 2022, 21:43:57 UTC
- Prior SEC filing
- 17 Jun 2021
- Next SEC filing
- 31 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Susan M. Kanaya, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David E. Wheadon filed Form 4 for ChemoCentryx, Inc. on 31 May 2022.
Change
- Previous filing in this sequence was filed on 17 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CCXI
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- Shares
- +22,274
- Change %
- Price
- Shares after
- 22,274
- Date
- 26 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,274
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
Footnote F2
The restricted stock units awarded on May 26, 2022, vest in three equal installments on May 26, 2023, May 26, 2024, and May 26, 2025, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.